Accessibility Menu
Golden Ally Lifetech Group logo

Golden Ally Lifetech Group(OTC) AQPW

Current Price$0.00
Market Cap$740.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2007)-100%
5 Year-100%
1 Year-50%
1 Month+0%
Golden Ally Lifetech Group last closing stock price
MetricPriceDate
Last closeUSD 0.002026-07-06
Golden Ally Lifetech Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-04-22
1 month+0%USD 0.002026-04-22
3 month+0%USD 0.002026-03-17
Year to date+0%USD 0.002025-12-02
1 year-50%USD 0.002025-06-27
3 year-99.96%USD 0.272023-07-07
5 year-99.95%USD 0.182021-07-07
Since inception-99.98%USD 0.602007-03-14

Golden Ally Lifetech Group Financials at a Glance

Market Cap

$740.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

-$6.52M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-183.60 (Low)

Price

$0.00

Volume

15

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Nov 27, 2024

AQPW News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Golden Ally Lifetech Group

Golden Ally Lifetech Group, Inc. is a developmental stage company focused on innovation in advanced technologies, energy solutions, and medical equipment. The firm is actively engaged in the bioscience and sports medicine sectors, developing a range of products aimed at improving health and safety.

Products and Services
  • Sterilal self-sanitizing devices for enhanced hygiene
  • PASS smart denture mouth guards for oral health
  • InCharge magnetic battery device for energy solutions
Growth Outlook
  • Continued development of innovative medical devices positions the company for future growth
  • Expansion into graphene-based applications for aviation could open new markets
  • Focus on bioscience and sports medicine aligns with increasing health awareness trends
Financial Highlights
  • Recent quarterly revenue of $0, indicating early-stage development
  • Cash and cash equivalents of $191,041 as of March 31, 2023
  • Current ratio of 16.51 suggests strong short-term financial health
Golden Ally Lifetech Group, Inc. is positioned in a niche market with significant potential for growth. The company's focus on innovative health solutions and energy technologies aligns with current trends in health and wellness. Despite reporting no revenue in recent quarters, the strong current ratio indicates a solid liquidity position, allowing for continued investment in product development. The ongoing advancements in medical technology and energy solutions could provide substantial opportunities for future revenue generation.
AI Generated • Jul 17, 2026

Industry

Beverages

Employees

11

CEO

Oliver Keren Ban

Headquarters

Austin, TX 78746, US

AQPW Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-772.01%

Return on Capital

-358.82%

Return on Assets

-352.83%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$740.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

7.41B

Volume

15

Avg. Volume

0.242

Financials (TTM)

Gross Profit

-$57.59K

Operating Income

-$6.52M

EBITDA

-$6.46M

Operating Cash Flow

-$4.42M

Capital Expenditure

$0.00

Free Cash Flow

-$4.42M

Cash & ST Invst.

$191.04K

Total Debt

$83.81K

Golden Ally Lifetech Group Performance Analysis

Golden Ally Lifetech Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 0N/A
20222022-12-31USD 0N/A
Golden Ally Lifetech Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22022-06-30N/A
Q32022-09-30N/A
Q42022-12-31N/A
Q12023-03-31N/A
Golden Ally Lifetech Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD 0.00N/A
20222022-12-31USD -0.00N/A
Golden Ally Lifetech Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22022-06-3013.4%
Q32022-09-3016.5%
Q42022-12-3112.0%
Q12023-03-31-123.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q1 2023YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$17.28K

N/A

Gross Margin

0.00%

N/A

Market Cap

$740.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$74.09K

N/A

Employees

10

N/A

Net Income

-$2.43M

-23.7%

EBITDA

-$2.41M

-26.8%

Quarterly Fundamentals

Name
Q1 2023YOY CHG

Total Cash

$191.04K

-96.7%

Total Debt

$83.81K

N/A

Accounts Receivable

$1.00M

N/A

Inventory

$0.00

N/A

Long Term Debt

$12.55K

N/A

Short Term Debt

$142.51K

N/A

Return on Assets

-3.53%

N/A

Return on Invested Capital

-3.74%

N/A

Free Cash Flow

-$665.14K

+71.5%

Operating Cash Flow

-$665.14K

+71.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
VGGIFBoosh Plant-Based Brands, Inc.
$0.00+0.00%
ALKMAlkame Holdings, Inc.
$0.00+0.00%
FBECFBEC Worldwide, Inc.
$0.00+0.00%
INKWGreene Concepts, Inc.
$0.00+17.65%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$92.32-0.08%
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%

Questions About AQPW

What is the current price of Golden Ally Lifetech Group?

Golden Ally Lifetech Group is trading at $0.00 per share.

What is the 52-week range for Golden Ally Lifetech Group?

Over the past 52 weeks, Golden Ally Lifetech Group has traded between $0.00 and $0.00.

How much debt does Golden Ally Lifetech Group have?

As of the most recent reporting period, Golden Ally Lifetech Group reported total debt of $100.58K.

How much cash does Golden Ally Lifetech Group have on hand?

Golden Ally Lifetech Group reported $581.97K in cash and cash equivalents in its most recent financial results.

What is Golden Ally Lifetech Group’s dividend yield?

Golden Ally Lifetech Group does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.